The Latin America, Middle East and Africa Radiation Oncology Market is expected to witness market growth of 14.9% CAGR during the forecast period (2022-2028).
A device that can produce photons or particles, such as electrons, protons, carbon ions, or neutrons, is used to produce radiation energy in the majority of external radiation treatments. The most popular type of radiation oncology is by far high-energy photons (6-20 MV), which are produced by linear accelerators that are readily available on the market. The linear accelerator gantry is free to spin around the treatment table while the patients are reproducibly positioned on a fixed treatment table, with radiation being delivered onto the patient's tumor from various angles.
Using radioactive sources, radiation can also be applied to the tissue nearby or termed brachytherapy. Technology advancements have occasionally made it possible to treat tumors more effectively from a therapeutic standpoint. The usefulness of a novel radiation technology depends on several variables, such as the inherent radio responsiveness of the tumor, the vulnerability of the nearby normal tissue to radiation injury, and the non-radiotherapeutic treatments that are available for a certain cancer diagnosis.
African countries' awareness of the growing health danger posed by non-communicable diseases (NCDs), such as cancer, was underlined by the Brazzaville Declaration on Noncommunicable Disease Prevention and Control in the WHO African Region, issued in 20112. In addition to creating prevention and control plans, the signatories pledged to improve their health systems to reduce NCD burdens, raise funds to fight these illnesses, and support the production of NCD-related data by their national health information systems.
The Brazil market dominated the LAMEA Radiation Oncology Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $273.7 million by 2028.The Argentina market is experiencing a CAGR of 15.5% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 14.6% during (2022 - 2028).
Based on Application, the market is segmented into Breast Cancer, Gynecological Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Head & Neck Cancer, Gynecological Cancer and Others. Based on Type, the market is segmented into External Beam Radiation Therapy and Internal Beam Radiation Therapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Varian Medical Systems, Inc., Ion Beam Applications SA, Elekta AB, Accuray Incorporated, Nordion Inc. (Sotera Health LLC), Isoray Inc., Mevion Medical Systems, Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.
A device that can produce photons or particles, such as electrons, protons, carbon ions, or neutrons, is used to produce radiation energy in the majority of external radiation treatments. The most popular type of radiation oncology is by far high-energy photons (6-20 MV), which are produced by linear accelerators that are readily available on the market. The linear accelerator gantry is free to spin around the treatment table while the patients are reproducibly positioned on a fixed treatment table, with radiation being delivered onto the patient's tumor from various angles.
Using radioactive sources, radiation can also be applied to the tissue nearby or termed brachytherapy. Technology advancements have occasionally made it possible to treat tumors more effectively from a therapeutic standpoint. The usefulness of a novel radiation technology depends on several variables, such as the inherent radio responsiveness of the tumor, the vulnerability of the nearby normal tissue to radiation injury, and the non-radiotherapeutic treatments that are available for a certain cancer diagnosis.
African countries' awareness of the growing health danger posed by non-communicable diseases (NCDs), such as cancer, was underlined by the Brazzaville Declaration on Noncommunicable Disease Prevention and Control in the WHO African Region, issued in 20112. In addition to creating prevention and control plans, the signatories pledged to improve their health systems to reduce NCD burdens, raise funds to fight these illnesses, and support the production of NCD-related data by their national health information systems.
The Brazil market dominated the LAMEA Radiation Oncology Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $273.7 million by 2028.The Argentina market is experiencing a CAGR of 15.5% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 14.6% during (2022 - 2028).
Based on Application, the market is segmented into Breast Cancer, Gynecological Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Head & Neck Cancer, Gynecological Cancer and Others. Based on Type, the market is segmented into External Beam Radiation Therapy and Internal Beam Radiation Therapy. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Varian Medical Systems, Inc., Ion Beam Applications SA, Elekta AB, Accuray Incorporated, Nordion Inc. (Sotera Health LLC), Isoray Inc., Mevion Medical Systems, Inc., Provision Healthcare, and Panacea Medical Technologies Pvt. Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Application- Breast Cancer
- Gynecological Cancer
- Colorectal Cancer
- Lung Cancer
- Prostate Cancer
- Head & Neck Cancer
- Gynecological Cancer
- Others
- External Beam Radiation Therapy
- Internal Beam Radiation Therapy
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Varian Medical Systems, Inc.
- Ion Beam Applications SA
- Elekta AB
- Accuray Incorporated
- Nordion Inc. (Sotera Health LLC)
- Isoray Inc.
- Mevion Medical Systems, Inc.
- Provision Healthcare
- Panacea Medical Technologies Pvt. Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Radiation Oncology Market by Application
Chapter 5. LAMEA Radiation Oncology Market by Type
Chapter 6. LAMEA Radiation Oncology Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Varian Medical Systems, Inc.
- Ion Beam Applications SA
- Elekta AB
- Accuray Incorporated
- Nordion Inc. (Sotera Health LLC)
- Isoray Inc.
- Mevion Medical Systems, Inc.
- Provision Healthcare
- Panacea Medical Technologies Pvt. Ltd.
Methodology
LOADING...
